Riley Griffin

Stay informed with Riley Griffin’s coverage and analysis for Fortune.

Page 3 of 4

  • In this photo illustration a medical syringe seen displayedHealth

    Johnson & Johnson asks FDA for emergency authorization of its single-dose COVID vaccine

    By Riley Griffin and Bloomberg
  • F500-2020-069-MerckHealth

    Merck ends development of two COVID-19 vaccines after weak trial results

    By Bloomberg and Riley Griffin
  • A health worker sorts blood samples for Covid-19 vaccination study at the Center for Pediatrics Infectology Studies (CEIP) where the pharmaceutical company Janssen, of Johnson &aJohnson, is developing the phase 3 study of the vaccine in Cali, Colombia on November 26, 2020. – The World Health Organization (WHO) has identified 48 “candidate vaccines” at the stage of clinical trials in humans by mid-November, but only 11 at the most advanced Phase 3 stage. The WHO has identified another 164 vaccine projects that are still in the pre-clinical phase of development. (Photo by Luis ROBAYO / AFP) (Photo by LUIS ROBAYO/AFP via Getty Images)Health

    J&J says efficacy of one-shot COVID-19 vaccine could beat expectations

    By Riley Griffin and Bloomberg
  • Syringes wand vials of the Pfizer-BioNTech COVID-19 vaccine are prepared to be administered to front-line health care workers under an emergency use authorization at a drive up vaccination site from Renown Health in Reno, Nev. on December 17, 2020.Health

    Pfizer to supply U.S. with 100 million more vaccine doses

    By John Lauerman, Riley Griffin, and others
  • ITALY-HEALTH-VIRUS-SCIENCE-TECHNOLOGY-PHARMACEUTICALS-VACCINE-MAHealth

    U.S. plan to vaccinate most Americans by summer depends on AstraZeneca and J&J

    By Riley Griffin and Bloomberg
  • KIEV, UKRAINE – 2018/12/16: In this photo illustration, the Eli Lilly and Company Pharmaceutical company logo seen displayed on a smartphone. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)Health

    Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA

    By Riley Griffin and Bloomberg
  • Prime Minister Scott Morrison Announces Two New COVID-19 Vaccine Supply AgreementsInternational

    Germany funded the development of Pfizer’s COVID vaccine—not U.S.’s Operation Warp Speed

    By Riley Griffin, Drew Armstrong, and others
  • ANKARA, TURKEY – OCTOBER 27: Injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus (COVID-19) pandemic by the U.S. Pfizer and German BioNTech company, are seen at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. This vaccine candidate, within the scope of phase 3 studies, was injected to volunteers in Ankara University Ibni Sina Hospital. (Photo by Dogukan Keskinkilic/Anadolu Agency via Getty Images)Health

    Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections

    By Robert Langreth, Naomi Kresge, and others
  • ARGENTINA-HEALTH-VIRUS-VACCINE-LABORATORYInternational

    Some scientists downplay significance of AstraZeneca’s COVID-19 vaccine trial halt

    By Michelle Fay Cortez, Riley Griffin, and others
  • Senate HELP Committee Holds Hearing On Safely Going Back To Work And School During PandemicHealth

    Anthony Fauci says coronavirus vaccine immunity is likely to be ‘finite’

    By Riley Griffin and Bloomberg
  • WASHINGTON, May 12, 2020 — Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a teleconference hearing hosted by a Senate panel on the White House’s response to the coronavirus, in Washington D.C., the United States, May 12, 2020. Anthony Fauci, a top expert on infectious diseases in the United […]Health

    Dr. Fauci’s worst nightmare? We’re living it

    By John Lauerman, Riley Griffin, and others
  • Paul Hudson, chief executive officer of Sanofi, is close to selling a stake in high-flying Regeneron Pharmaceuticals, a deal that could net the French pharma giant $13 billion.International

    France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries

    By James Paton, Riley Griffin, and others
  • Former Turing Pharmaceuticals CEO Martin Shkreli Jury To Start Deliberations In Fraud TrialHealth

    ‘Pharma bro’ Martin Shkreli sued for alleged violation of antitrust law

    By Erik Larson, Riley Griffin, and others
  • Merck, which makes Keytruda, will acquire ArQule, which develops kinase inhibitors, and Sanofi, the French drug giant, agreed to buy Synthorx, which is developing drugs including immunotherapies.Health

    Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology

    By Riley Griffin, James Paton, and others
  • Purdue Pharma bankruptcyHealth

    Sackler Family Backs $11B Settlement of Opioid Lawsuits That Would See Purdue Pharma File for Bankruptcy

    By Jef Feeley, Riley Griffin, and others